MMMartina Marras

Martina Marras

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Martina Marras has a total of 45 co-authors. Here are the top co-authors by number of shared publications:

  • Jonathan R. Silva

    Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO, USA

    9 shared publications
  • Anna Li

    Department of Biomedical Engineering, McKelvey School of Engineering, Washington University in St. Louis, St. Louis, MO, USA

    4 shared publications
  • Emily Wagner

    Department of Biomedical Engineering, McKelvey School of Engineering, Washington University in St. Louis, St. Louis, MO, USA

    4 shared publications
  • Lucy Woodbury

    Department of Biomedical Engineering, McKelvey School of Engineering, Washington University in St. Louis, St. Louis, MO, USA

    4 shared publications
  • Carlota Abella

    Department of Biomedical Engineering, Washington University in St.Louis, St. Louis, MO 63130, USA

    3 shared publications
  • Jingyi Shi

    Department of Biomedical Engineering, Washington University in St.Louis, St. Louis, MO 63130, USA

    3 shared publications

Latest Publications

  • Open Access

    Calmodulin acts as a selective switch in FGF12A-mediated regulation of the cardiac sodium channel Nav1.5

    by Lucy Woodbury, Paweorn Angsutararux, Martina Marras, Emily Wagner, Carlota Abella, Anna Li, Jonathan R. Silva

  • FGF12A confers calcium sensitivity to Nav1.5 inactivation via dynamic calmodulin recruitment

    by Lucy Woodbury, Anna Li, Paweorn Angsutararux, Martina Marras, Emily Wagner, Jonathan R. Silva

    Voltage‐gated Na + (Nav) channels, including Nav1.5, initiate cardiac and neuronal action potentials. Regulation of Nav1.5 inactivation is linked to multiple accessory proteins that bind its C‐terminal domain (CTD), including calmodulin (CaM) and intracellular fibroblast growth factors (iFGFs). Previous results demonstrate that Ca 2+ ‐saturated CaM binds the FGF12A N‐terminus. The role of intracellular Ca 2+ ([Ca 2+ ] i ) in regulating Nav1.5 gating, either directly or via auxiliary proteins such as CaM, is controversial. We hypothesize that CaM binding to the Nav1.5 CTD and to FGF12A synergistically alters channel inactivation in a previously unobserved calcium‐dependent manner. We performed fluorescence resonance energy transfer (FRET) imaging in live cells to observe the interaction between the YFP (acceptor)‐tagged FGF12A and Nav1.5 α subunit to the CFP (donor)‐tagged CaM. At resting [Ca 2+ ] i a twofold difference between acceptor and donor FRET efficiencies was observed, signifying that a single CaM protein is present on the Nav1.5 CTD even in presence of FGF12A. After [Ca 2+ ] i was increased the donor and acceptor FRET efficiencies equalized, indicating that a second CaM is recruited to the Nav1.5:FGF12A complex. We then compared the voltage‐dependent gating kinetics of Nav1.5 with FGF12A across calcium conditions. At low [Ca 2+ ] i steady‐state inactivation of Nav1.5 with FGF12A was significantly shifted towards hyperpolarized potentials. At resting and elevated [Ca 2+ ] i inactivation was dramatically altered in the depolarizing direction. These results demonstrate that the FGF12A:CaM complex enables Ca 2+ ‐dependent modulation of Nav1.5's voltage‐dependent gating kinetics. image Key points: The dependence of Nav1.5 gating on intracellular Ca 2+ concentration remains controversial, and the underlying mechanisms of regulation are unclear. Fluorescence resonance energy transfer (FRET)‐based imaging is capable of detecting changes in subunit stoichiometry in live cells. Increased intracellular Ca 2+ leads to additional calmodulin (CaM) binding within the Nav1.5 complex as measured using FRET. Ca 2+ ‐dependent binding of CaM to FGF12A on the Nav1.5 complex alters inactivation gating.


  • Open Access

    Common genetic variants of the cardiac sodium channel alter patient response to class 1b antiarrhythmics

    by Martina Marras, Joshua D. Josef, Thomas Schuster, Heather L. Struckman, Emily S. Wagner, Lucas Lee, Kyle J. Smith, Janice M. Amsler, Lucy S. Woodbury, Erica Marquez, et al.

  • Open Access

    Calcium interaction with Nav1.5 via FGF12A and CaM binding

    by Lucy Woodbury, Anna Li, Paweorn Angsutararux, Martina Marras, Emily Wagner, Jonathan R. Silva

    Voltage-gated Na + (Nav) channels, including Nav1.5, are responsible for the initiation of cardiac and neuronal action potentials. Regulation of Nav1.5 inactivation is linked to multiple accessory proteins that bind its C-terminal domain (CTD) including calmodulin (CaM) and intracellular fibroblast growth factors (iFGF). Previous results demonstrate that Ca 2+ -bound CaM preferentially binds to iFGF12A. The role of intracellular Ca 2+ ([Ca 2+ ] i ) in regulating Nav1.5 gating, either directly or via auxiliary proteins like CaM, is controversial. We hypothesize that CaM binding to the Nav1.5 CTD and iFGF12A synergistically alters channel inactivation in a previously unobserved calcium-dependent manner. We performed Fluorescence Resonance Energy Transfer (FRET) imaging in live cells to observe the interaction between the Nav1.5 alpha subunit, CaM and iFGF12A. At resting [Ca 2+ ] i , a 2-fold difference between acceptor and donor FRET efficiency was observed, implying that a single CaM acceptor is present on the Nav1.5 CTD even in the presence of FGF12A. After increasing [Ca 2+ ] i , the donor and acceptor FRET efficiencies equalize, suggesting a 2:1:1 ratio between CaM, FGF12A, and the Nav1.5 CTD. We then compared the voltage-dependent gating kinetics of Nav1.5 with FGF12A in the presence/absence of calcium. With low [Ca 2+ ] i , the steady-state inactivation of Nav1.5 with FGF12A was significantly shifted toward hyperpolarized potential compared to resting [Ca 2+ ] i . Thus, the FGF12A:CaM complex confers a Ca 2+ -dependent mechanism enabling FGF12A modulates the Nav1.5 steady-state inactivation. Additionally, the ability of multiple subunits to bring CaM to the Nav1.5 CTD implies biological redundancy to prevent major alteration to Nav1.5 inactivation in the absence of CaM.

  • Open Access

    Common Genetic Variants of The Cardiac Sodium Channel Alter Patient Response to Class 1b Antiarrhythmics

    by Martina Marras, Joshua D. Josef, Thomas Schuster, Heather L. Struckman, Emily Wagner, Lucas Lee, Kyle J. Smith, Janice M. Amsler, Lucy S. Woodbury, Erica Marquez, et al.

    Several common variants have been identified in SCN5A, which encodes the cardiac sodium channel α-subunit Nav1.5 and is targeted by class I antiarrhythmics. Lidocaine and its analog mexiletine both have a primary amine that blocks Na + current. While lidocaine is highly effective in terminating ventricular tachycardia after acute myocardial infarction, mexiletine has been shown to prevent arrhythmia induction in only ∼20% of patients. The factors underlying this inconsistent drug response are unclear. Here, we use cardiomyocytes that are derived from induced pluripotent stem cells to observe that a common polymorphism in the SCN5A gene, S1103Y, exhibits an altered pharmacological response to mexiletine, with enhanced use-dependent and tonic block of peak sodium current. In addition, an unexpected increase in late sodium current causes action potential prolongation. This paradoxical proarrhythmic phenotype shifts the paradigm of conventional antiarrhythmic therapy with mexiletine, suggesting that background variants may alter pharmacological responses leading to unanticipated consequences. Our results suggest that the unique genetic background of patients should inform therapeutic approaches to treat and prevent arrhythmias associated with common cardiac pathologies.

  • Investigating the role of the I–II linker in Nav1.5 channel function

    by Emily Wagner, Martina Marras, Shashi Kumar, Jacob Kelley, Kiersten Ruff, Jonathan Silva

    The cardiac voltage-gated sodium channel, Nav1.5, initiates the cardiac action potential. Its dysfunction can lead to dangerous arrhythmias, sudden cardiac arrest, and death. The functional Nav1.5 core consists of four homologous repeats (I, II, III, and IV), each formed from a voltage sensing and a pore domain. The channel also contains three cytoplasmic linkers (I–II, II–III, and III–IV). While Nav1.5 structures have been published, the I–II and II–III linkers have remained absent, are predicted to be disordered, and their functional role is not well understood. We divided the I–II linker into eight regions ranging in size from 32 to 52 residues, chosen based on their distinct properties. Since these regions had unique sequence properties, we hypothesized that they may have distinct effects on channel function. We tested this hypothesis with experiments with individual Nav1.5 constructs with each region deleted. These deletions had small effects on channel gating, though two (430–457del and 556–607del) reduced peak current. Phylogenetic analysis of the I–II linker revealed five prolines (P627, P628, P637, P640, and P648) that were conserved in mammals but absent from the Xenopus sequence. We created mutant channels, where these were replaced with their Xenopus counterparts. The only mutation that had a significant effect on channel gating was P627S, which depolarized channel activation (10.13 ± 2.28 mV). Neither a phosphosilent (P627A) nor a phosphomimetic (P627E) mutation had a significant effect, suggesting that either phosphorylation or another specific serine property is required. Since deletion of large regions had little effect on channel gating while a point mutation had a conspicuous impact, the I–II linker role may be to facilitate interactions with other proteins. Variants may have a larger impact if they create or disrupt these interactions, which may be key in evaluating the pathogenicity of variants.


  • Open Access

    FGF12A Regulates Nav1.5 via CaM-regulated and CaM-independent Mechanisms

    by Lucy S Woodbury, Paweorn Angsutararux, Martina Marras, Emily S Wagner, Carlota Abella, Anna Li, Jonathan R. Silva

    Opening of the cardiac voltage-gated Na+ channel (Nav1.5) is responsible for robust depolarization of the cardiac action potential, while inactivation, which rapidly follows, allows for repolarization. Regulation of both the voltage- and time-dependent kinetics of Nav1.5 inactivation can alter the ability of the heart to initiate and sustain a re-entrant arrhythmia. The C-terminal domain (CTD) of Nav1.5 has been shown to modulate fast inactivation of the channel, and multiple auxiliary proteins bind to the CTD, including calmodulin (CaM) and intracellular fibroblast growth factor 12A (FGF12A). Recently, a non-canonical CaM-binding site was also discovered on the N-terminal of A-splice variants of iFGFs. We performed cut-open Vaseline gap (COVG) voltage-clamp to test whether FGF12A with and without CaM regulates Nav1.5 gating. In WT Nav1.5 channels, FGF12A with and without CaM present had a minimal effect on the voltage dependence of both activation and inactivation. Conversely, when CaM is absent on the Nav1.5 CTD (IQ/AA), a dramatic shift in steady-state inactivation (SSI) occurred, regardless of whether CaM was present on FGF12A. These two distinct mechanisms are operative in Nav1.5 LQT3 mutations where FGF12A requires CaM to shift in the voltage-dependence of inactivation, but not to inhibit the persistent late current. We conclude that there are two distinct mechanisms by which FGF12A modulates the Nav1.5 channel: CaM-regulated alteration of the voltage dependence of inactivation and CaM-independent inhibition of persistent late current.


  • Open Access

    Arrhythmia-associated calmodulin variants interact with KCNQ1 to confer aberrant membrane trafficking and function

    by Po Wei Kang, Lucy Woodbury, Paweorn Angsutararux, Namit Sambare, Jingyi Shi, Martina Marras, Carlota Abella, Anish Bedi, DeShawn Zinn, Jianmin Cui, et al.

    Missense variants in calmodulin (CaM) predispose patients to arrhythmias associated with high mortality rates (“calmodulinopathy”). As CaM regulates many key cardiac ion channels, an understanding of disease mechanism associated with CaM variant arrhythmias requires elucidating individual CaM variant effects on distinct channels. One key CaM regulatory target is the KCNQ1 (KV7.1) voltage-gated potassium channel that carries the IKs current. Yet, relatively little is known as to how CaM variants interact with KCNQ1 or affect its function. Here, we take a multipronged approach employing a live-cell fluorescence resonance energy transfer binding assay, fluorescence trafficking assay, and functional electrophysiology to characterize >10 arrhythmia-associated CaM variants for effect on KCNQ1 CaM binding, membrane trafficking, and channel function. We identify one variant (G114W) that exhibits severely weakened binding to KCNQ1 but find that most other CaM variants interact with similar binding affinity to KCNQ1 when compared with CaM wild-type over physiological Ca2+ ranges. We further identify several CaM variants that affect KCNQ1 and IKs membrane trafficking and/or baseline current activation kinetics, thereby delineating KCNQ1 dysfunction in calmodulinopathy. Lastly, we identify CaM variants with no effect on KCNQ1 function. This study provides extensive functional data that reveal how CaM variants contribute to creating a proarrhythmic substrate by causing abnormal KCNQ1 membrane trafficking and current conduction. We find that CaM variant regulation of KCNQ1 is not uniform with effects varying from benign to significant loss of function, suggesting how CaM variants predispose patients to arrhythmia via the dysregulation of multiple cardiac ion channels. Classification: Biological, Health, and Medical Sciences, Physiology


  • Open Access

    Differential regulation of cardiac sodium channels by intracellular fibroblast growth factors

    by Paweorn Angsutararux, Amal K. Dutta, Martina Marras, Carlota Abella, Rebecca L. Mellor, Jingyi Shi, Jeanne M. Nerbonne, Jonathan R. Silva

    Voltage-gated sodium (NaV) channels are responsible for the initiation and propagation of action potentials. In the heart, the predominant NaV1.5 α subunit is composed of four homologous repeats (I–IV) and forms a macromolecular complex with multiple accessory proteins, including intracellular fibroblast growth factors (iFGF). In spite of high homology, each of the iFGFs, iFGF11–iFGF14, as well as the individual iFGF splice variants, differentially regulates NaV channel gating, and the mechanisms underlying these differential effects remain elusive. Much of the work exploring iFGF regulation of NaV1.5 has been performed in mouse and rat ventricular myocytes in which iFGF13VY is the predominant iFGF expressed, whereas investigation into NaV1.5 regulation by the human heart-dominant iFGF12B is lacking. In this study, we used a mouse model with cardiac-specific Fgf13 deletion to study the consequences of iFGF13VY and iFGF12B expression. We observed distinct effects on the voltage-dependences of activation and inactivation of the sodium currents (INa), as well as on the kinetics of peak INa decay. Results in native myocytes were recapitulated with human NaV1.5 heterologously expressed in Xenopus oocytes, and additional experiments using voltage-clamp fluorometry (VCF) revealed iFGF-specific effects on the activation of the NaV1.5 voltage sensor domain in repeat IV (VSD-IV). iFGF chimeras further unveiled roles for all three iFGF domains (i.e., the N-terminus, core, and C-terminus) on the regulation of VSD-IV, and a slower time domain of inactivation. We present here a novel mechanism of iFGF regulation that is specific to individual iFGF isoforms and that leads to distinct functional effects on NaV channel/current kinetics.


  • Open Access

    An allosteric modulator activates BK channels by perturbing coupling between Ca2+ binding and pore opening

    by Guohui Zhang, Xianjin Xu, Zhiguang Jia, Yanyan Geng, Hongwu Liang, Jingyi Shi, Martina Marras, Carlota Abella, Karl L. Magleby, Jonathan R. Silva, et al.

    BK type Ca2+-activated K+channels activate in response to both voltage and Ca2+. The membrane-spanning voltage sensor domain (VSD) activation and Ca2+binding to the cytosolic tail domain (CTD) open the pore across the membrane, but the mechanisms that couple VSD activation and Ca2+binding to pore opening are not clear. Here we show that a compound, BC5, identified from in silico screening, interacts with the CTD-VSD interface and specifically modulates the Ca2+dependent activation mechanism. BC5 activates the channel in the absence of Ca2+binding but Ca2+binding inhibits BC5 effects. Thus, BC5 perturbs a pathway that couples Ca2+binding to pore opening to allosterically affect both, which is further supported by atomistic simulations and mutagenesis. The results suggest that the CTD-VSD interaction makes a major contribution to the mechanism of Ca2+dependent activation and is an important site for allosteric agonists to modulate BK channel activation.